What are the advantages of the Oxford—AstraZeneca COVID-19 vaccine?

0

While the latest set of interim vaccine results from Oxford University and AstraZeneca include an efficacy score of 70%, significantly lower than the results of competitors, the new vaccine bears other advantages.

These include the ability to be transported and stored at temperatures closer to room temperature, easier and more efficient production and being sold at cost throughout the duration of the pandemic.

READ MORE ON BIOTECHNIQUES NOW

Share:

Leave A Comment